PriceTargets.com logo

Bausch Health Companies - BHC Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$10.32 As of 12/4/2025 05:00 PM ET
▲ +0.47 (4.77%)

This chart shows the closing price for BHC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Bausch Health Companies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BHC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BHC

Analyst Price Target is C$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Bausch Health Companies in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$10.32.

This chart shows the closing price for BHC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Bausch Health Companies. This rating has held steady since October 2025, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/15/2024Evercore ISIUpgradeHold
7/10/2024Raymond James FinancialUpgradeHold
2/23/2024Royal Bank Of CanadaBoost TargetSector PerformC$8.00 ➝ C$9.00
10/23/2023Royal Bank Of CanadaLower TargetSector PerformC$9.00 ➝ C$8.00
5/5/2023Royal Bank Of CanadaLower TargetSector PerformC$9.00 ➝ C$8.00
2/24/2023Royal Bank Of CanadaBoost TargetSector PerformC$8.00 ➝ C$9.00
8/8/2022GuggenheimBoost TargetC$24.00 ➝ C$26.00
2/25/2022Royal Bank Of CanadaLower TargetOutperformC$34.00 ➝ C$32.00
2/1/2022Royal Bank Of CanadaLower TargetOutperformC$43.00
4/30/2021Royal Bank Of CanadaReiterated RatingOutperformC$51.50
2/25/2021BarclaysBoost TargetOverweightC$44.00
2/18/2021Royal Bank Of CanadaBoost TargetNAC$42.00
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.63 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 7 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 2 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 1 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 2 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 2 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Bausch Health Companies logo
Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
Read More

Today's Range

Now: C$10.32
Low: C$9.86
High: C$10.52

50 Day Range

MA: C$9.01
Low: C$8.22
High: C$10.32

52 Week Range

Now: C$10.32
Low: C$5.91
High: C$12.07

Volume

569,843 shs

Average Volume

381,573 shs

Market Capitalization

C$3.82 billion

P/E Ratio

10.64

Dividend Yield

0.76%

Beta

0.757326

Frequently Asked Questions

What sell-side analysts currently cover shares of Bausch Health Companies?

The following Wall Street analysts have issued stock ratings on Bausch Health Companies in the last twelve months:
View the latest analyst ratings for BHC.

What is the current price target for Bausch Health Companies?

0 Wall Street analysts have set twelve-month price targets for Bausch Health Companies in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for Bausch Health Companies in the next year.
View the latest price targets for BHC.

What is the current consensus analyst rating for Bausch Health Companies?

Bausch Health Companies currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for BHC.

What other companies compete with Bausch Health Companies?

Other companies that are similar to Bausch Health Companies include Tilray Brands, Aphria, Premium Brands, Aurinia Pharmaceuticals and Solaris Resources. Learn More about companies similar to Bausch Health Companies.

How do I contact Bausch Health Companies' investor relations team?

Bausch Health Companies' physical mailing address is 2150 Saint-Elzear Blvd W, Laval, Quebec H7L 4A8. The company's listed phone number is 514-744-6792. The official website for Bausch Health Companies is www.valeant.com. Learn More about contacing Bausch Health Companies investor relations.